Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Immunology Letters|April 26, 2011
Selective elimination of pathogenic synovial fluid T-cells from rheumatoid arthritis and juvenile idiopathic arthritis by targeted activation of Fas-apoptotic signalingEdwin Bremer, Wayel H Abdulahad, Marco de Bruyn, et al.
Arthritis Research & Therapy|December 17, 2011
Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjectsPaul Eggleton, Edwin Bremer, Joanna M Tarr, et al.
Multiple Sclerosis and Related Disorders|August 13, 2015
CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic eliminationJanet E Holley, Edwin Bremer, Alexandra C Kendall, et al.
Molecular Cancer|November 25, 2010
Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivoMarco de Bruyn, Anna A Rybczynska, Yunwei Wei, et al.
Oncoimmunology|July 3, 2015
CD20+ T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancerMarco de Bruyn, Valerie R Wiersma, Maartje C A Wouters, et al.
Cancer Research|April 19, 2005
Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7Edwin Bremer, Douwe F Samplonius, Matthias Peipp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2011
Cell surface delivery of TRAIL strongly augments the tumoricidal activity of T cellsMarco de Bruyn, Yunwei Wei, Valerie R Wiersma, et al.
ISRN Oncology|July 11, 2013
Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapyEdwin Bremer
Cancers|August 12, 2023
Applications of Anti-Cytomegalovirus T Cells for Cancer (Immuno)TherapyIsabel Britsch, Anne Paulien van Wijngaarden, Wijnand Helfrich
Molecular Cancer|April 19, 2014
Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell deathKim L Brunekreeft, Corinna Strohm, Marloes J Gooden, et al.
Pageof 13